Impact of Ketogenic Diet on Seizure Frequency – Long-Term Effectiveness Studies
Dravet Syndrome is often resistant to conventional antiseizure medications, prompting families and clinicians to explore dietary therapies such as the ketogenic diet. This high-fat, low-carbohydrate regimen shifts the body’s metabolism toward ketosis, a state in which ketones become the primary fuel source for the brain, potentially stabilizing neuronal activity and reducing seizures.
Long-term studies have shown the ketogenic diet can lead to meaningful seizure reductions in Dravet Syndrome patients. In some cohorts, 30–50% of children achieved at least a 50% reduction in seizure frequency, with benefits persisting for several years when the diet was maintained. Importantly, the diet has also been associated with improved alertness, attention, and motor skills, which may enhance quality of life.
While the exact mechanism remains unclear, theories suggest that ketones enhance mitochondrial energy production, modulate neurotransmitter balance, and reduce neuronal excitability. Some evidence also points to anti-inflammatory and neuroprotective effects.
However, the ketogenic diet requires strict medical supervision. Potential side effects include gastrointestinal discomfort, kidney stones, slowed growth, and nutritional deficiencies. Regular monitoring and supplementation are essential. Modified versions such as the medium-chain triglyceride (MCT) diet or low-glycemic index treatment can improve tolerability.
The ketogenic diet is not a cure, but when combined with pharmacologic treatments, it can be a valuable adjunct therapy—particularly for patients with drug-resistant seizures. Continued research into its long-term metabolic effects will help optimize its role in managing Dravet Syndrome.